SLC12A9-AS1

Across TCGA pan-cancer cohorts, SLC12A9-AS1 RNA differs between tumor and matched normal tissue in 14 of 18 cancer types tested, making tumor–normal expression one of SLC12A9-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where SLC12A9-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SLC12A9-AS1 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

COAD, KIRC, and STAD are the cancer types where SLC12A9-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SLC12A9-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	+2.005	<.001	12	view →
KIRC	Female	III,IV	+1.012	<.001	12	view →
STAD	Male	II,III,IV	+1.184	<.001	9	view →
LUSC	Female	II,III,IV	+1.662	<.001	8	view →
LUAD	Female	III,IV	+1.442	<.001	8	view →
LIHC	Male	II,III,IV	+0.984	<.001	8	view →
HNSC	All	All	+0.508	.001	8	view →
READ	All	All	+1.494	<.001	6	view →
CHOL	All	All	+2.174	<.001	5	view →
KICH	Female	All	−0.924	<.001	5	view →
BLCA	All	III,IV	+0.705	.008	4	view →
KIRP	All	II,III,IV	+0.567	.017	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 14 lineages.

SLC12A9-AS1–COAD

Open the COAD breakdown →